Skip to main content
. 2020 May 13;15:92. doi: 10.1186/s13019-020-01136-9

Table 2.

Cardiac surgical procedure, intraoperatory parameters and fetal outcomes

Patient No. Cardiac surgical procedure Size of the cardiac valves/defects (mm) Aortic cross-clamp time (minutes) CPB time (minutes) CPB maximum flow (L) CPB
minimum temperature (°C)
Fetal outcomes
1 atrial septal defect closure 45 10 40 3.7 35.8 term birth, alive
2 mitral and tricuspid valve repair / 60 96 5.8 35.3 term birth, alive
3 right ventricle outlet obstructio-n repair / 20 47 4.7 35.4 preterm birth, alive
4 MVR 27 47 75 4.5 36 termination of pregnancy
5 MVR 25 66 102 5.5 35.5 term birth, alive
6 MVR 25 31 52 5 36.5 preterm birth, alive
7 MVR+ atrial septal defect closure 27/13 35 62 4.5 35.7 preterm birth, alive
8 AVR 24 75 112 4.6 34.4 term birth, alive
9 prosthetic mitral valve thrombect-omy + mitr-al valve repair / 101 133 4.9 34.8 abnormity of the brain, termination of pregnancy
10 atrial septal defect closure 35 18 35 3.5 34.9 term birth, alive
11 MVR 23 120 170 4.8 30 term birth, alive
12 ventricula-r septal defect closure 13.8 30 72 4.5 35.1 term birth, alive
13 atrial septal defect closure 21.7 21 40 4.2 35.8 term birth, alive
14 AVR 19 95 122 5 34.7 preterm birth,death
15 ventricula-r septal defect closure+ AVR 16.3/23 78 97 5.2 36.6 term birth, alive
16 atrial septal defect closure 30 13 25 4.5 36.2 term birth, alive
17 Betall procedure / 172 241 4.5 30 death in utero
18 MVR 29 32 57 4.4 36.3 death in utero
19 MVR 25 31 52 4.98 36 preterm birth, death
20

atrial septal defect closure+

ventricula-r septal defect closure

12/25 35 74 4.3 34.1 death in utero
21 ruptured sinus of Valsalva repair+ valves thrombect-omy / 163 211 4.1 33.1 termination of pregnancy
22 prosthetic aortic valve thrombect-omy / 65 174 4.0 17.7 death in utero

mm Millimetre, L Litre, CPB Cardiopulmonary bypass, AVR Aortic valve replacement, MVR Mitral valve replacement